Security key
75943R102
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)
CUSIP: 75943R102
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 123,551,085
- Total 13F value
- $2,763,964,560
- Share change
- +1,007,011
- Put/Call ratio
- 30%
- SEC-reported price per share
- $22.37
- Number of holders
- 153
- Value change
- +$25,518,843
- Number of buys
- 94
- Number of sells
- 41
- Shares outstanding
- 4,389,099
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
153
Top holders
10
RLAY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Relay Therapeutics, Inc. SEC filings
Relay Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75943R102
Recent filing periods:
Ownership snapshot
Top reported holders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SB INVESTMENT ADVISERS (U...
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 636%
Showing 1-6 of 15 holder rows.
Quick read
SB INVESTMENT ADVISERS (UK) LTD leads the comparable SEC ownership view at 636%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.
Comparable ownership
Top 5
SB INVESTMENT ADVISERS (UK) LTD
636%
FMR LLC
304%
VANGUARD GROUP INC
162%
BlackRock Finance, Inc.
150%
PRICE T ROWE ASSOCIATES INC /MD/
121%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
636%
|
$467,408,000
27,904,963 shares
|
— | 30 Jun 2022 |
| FMR LLC |
13F
Company
|
304%
|
$223,362,000
13,335,055 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
162%
|
$118,900,000
7,098,454 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
150%
|
$110,168,000
6,577,178 shares
|
— | 30 Jun 2022 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
121%
|
$88,780,000
5,300,307 shares
|
— | 30 Jun 2022 |
| JPMORGAN CHASE & CO |
13F
Company
|
113%
|
$82,784,000
4,942,262 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
153
Shares
123,551,085
Rows available
153
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
137
Q3 2022 holders
153
Holder diff
16
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend